{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"LakeShore Biopharma Co., Ltd"},"Symbol":{"label":"Symbol","value":"LSBPW"},"Address":{"label":"Address","value":"BUILDING NO. 2, 38 YONGDA ROAD,DAXING BIOMEDICAL INDUSTRY PARK, DAXING, 102629, China"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Asia"},"CompanyDescription":{"label":"Company Description","value":"YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China."},"CompanyUrl":{"label":"Company Url","value":"https://www.lakeshorebio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Xu Wang","title":"Chief Executive Officer & Director"},{"name":"Zenaida Reynoso Mojares","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}